Department of Orthopaedic Surgery, Dongguk University Ilsan Hospital, Goyang, Korea.
J Hand Surg Asian Pac Vol. 2021 Jun;26(2):131-141. doi: 10.1142/S2424835521400026.
Dupuytren disease (DD) is a fibroproliferative disorder that originates at the palmar fascia and results in flexion contracture of the digits. The gold standard treatment for DD has been surgery. Surgical treatment of DD can be done with various methods, from percutaneous needle fasciotomy to dermatofasciectomy. The most commonly used surgical treatment is limited fasciectomy (LF). The potential complications of limited fasciectomy include long recovery time, scarring, neurovascular injury, and tendon injury. Minimally invasive treatment for DD, which is simple and allows for rapid return of function, has gained popularity amongst both patients and surgeons. Currently, minimally invasive treatments for DD include percutaneous needle fasciotomy (PNF) and collagenase clostridium histolyticum (CCH). In this review, we provide an overview of the minimally invasive treatments for Dupuytren disease and summarize the current evidence regarding these minimally invasive treatments.
掌腱膜挛缩症（Dupuytren 病，DD）是一种纤维增生性疾病，起源于掌筋膜，导致手指弯曲挛缩。DD 的金标准治疗方法一直是手术。DD 的手术治疗可以采用多种方法，从经皮针刀筋膜切开术到皮肤筋膜切除术。最常用的手术治疗是有限筋膜切除术（LF）。有限筋膜切除术的潜在并发症包括恢复时间长、疤痕、血管神经损伤和肌腱损伤。DD 的微创治疗方法简单，功能恢复迅速，在患者和外科医生中越来越受欢迎。目前，DD 的微创治疗方法包括经皮针刀筋膜切开术（PNF）和胶原酶组织溶解（CCH）。在这篇综述中，我们提供了 DD 的微创治疗方法概述，并总结了这些微创治疗方法的现有证据。
